Johnson & Johnson survey finds bladder cancer treatments impact patient quality of life
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Groundbreaking global survey captures the significant patient burden experienced with current standard-of-care bladder cancer treatments, underscoring urgency for continued innovation
May 14, 2026 4:01 PM EDTMore than 90% of patients surveyed who underwent bladder removal or received BCG report negative impact on most aspects of their livesAmong patients treated with BCG, three-quarters describe managing the treatment-related physical symptoms as humiliatingPatients and urologists point to the importance of advancing treatments that may better reflect patient preferences and quality-of-life considerations
WASHINGTON, May 14, 2026 /PRNewswire/ -- A new global survey of patient and urologist perception and experienceconducted in... More
